ArticleClinical journal of gastroenterology2026

Delayed and multisystem immune-related adverse events in MSI-high colon cancer treated with nivolumab plus ipilimumab.

Takato Maeda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.